Janssen: REMICADE® (infliximab): www.remicade.com/shared/ product/remicade/prescribing-information.pdf VELCADE® (bortezomib): www.velcade.com/files/ pdfs/velcade_prescribing_information.pdf XARELTO® (rivaroxaban): www.xareltohcp.com/sites/ default/files/pdf/xarelto_0.pdf#zoom=100 ZYTIGA® (abiraterone acetate): www.zytiga.com/sites/ default/files/pdf/full_product_information.pdf PREZISTA® (darunavir): www.prezista.com/sites/ default/files/pdf/us_package_insert.pdf#zoom=100 INVEGA® SUSTENNA® / XEPLION® (paliperidone palmitate): www.invegasustenna.com/important-productinformation SIMPONI® (golimumab): www.simponi.com/shared/ product/simponi/prescribing-information.pdf and Safe Returns, which enables patients to return used sharps for destruction: www.simponi.com/hcp/simponione-safereturns STELARA® (ustekinumab): www.stelarainfo.com/ pdf/prescribingInformation.pdf#zoom=100 and Safe Returns, which enables patients to return used sharps for destruction: www.stelarainfo.com/stelara-psoriasis/ self-injection NUCYNTA® (tapentadol): www.nucynta.com/sites/ default/files/pdf/Nucynta-PI.pdf#zoom=100 and disposal guidance: www.nucynta.com/sites/default/ files/pdf/nucyntaer-medication-guide.pdf We continue looking to expand product sustainability information for those brands already providing it and in working with the remainder to begin the sharing of this information.